Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models

Abstract

Gastrointestinal bleeding (GIB) accounts for a significant proportion of life-threatening bleeding cases occurring after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, data on GIB after haploidentical HSCT (haplo-HSCT) are not available. A total of 3180 patients received haplo-HSCT at Peking University People’s Hospital from January 2015 to November 2019, and GIB occurred in 188 of these patients (incidence of 5.9%). Platelet counts <30 × 109/L, viral hepatitis, acute kidney injury (AKI), gastrointestinal disease or bleeding before HSCT and sinusoidal obstruction syndrome (SOS) were determined to be significant risk factors for the occurrence of GIB after haplo-HSCT. Grade III-IV acute graft-versus-host disease (aGVHD), AKI, thrombotic microangiopathy (TMA), disseminated intravascular coagulation (DIC) and gastrointestinal disease or bleeding before HSCT were significantly related to mortality in patients with GIB after haplo-HSCT. The predictive models developed for the occurrence and mortality of GIB performed well in terms of discrimination, and they might assist clinicians with personalised strategies for GIB prevention and treatment in patients after haplo-HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flow chart of patient screening.
Fig. 2: Clinical outcomes of patients with GIB after haplo-HSCT.
Fig. 3: Estimation of GIB occurrence stratified by the predictive model.
Fig. 4: Survival of patients stratified by the predictive model for GIB.
Fig. 5: Performance of the predictive model on discriminating GIB following haplo-HSCT.
Fig. 6: Estimation of mortality of patients with GIB stratified by the predictive model.
Fig. 7: Performance of the predictive model on discriminating mortality of patients with GIB following haplo-HSCT.

Similar content being viewed by others

References

  1. Lv M, Chang Y, Huang X. Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Front Med. 2019;13:45–56. https://doi.org/10.1007/s11684-017-0595-7

    Article  PubMed  Google Scholar 

  2. Lv M, Huang XJ. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. J Hematol Oncol. 2012;5:10 https://doi.org/10.1186/1756-8722-5-10

    Article  PubMed  PubMed Central  Google Scholar 

  3. Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH, et al. A review of hematopoietic cell transplantation in China: data and trends during 2008-2016. Bone Marrow Transpl. 2017;52:1512–8. https://doi.org/10.1038/bmt.2017.59

    Article  CAS  Google Scholar 

  4. Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125:3956–62. https://doi.org/10.1182/blood-2015-02-627786

    Article  CAS  PubMed  Google Scholar 

  5. Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical versus matched-sibling transplant in adults with philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III Randomized Study. Clin Cancer Res. 2016;22:3467–76. https://doi.org/10.1158/1078-0432.CCR-15-2335

    Article  CAS  PubMed  Google Scholar 

  6. Wang Y, Wang HX, Lai YR, Sun ZM, Wu DP, Jiang M, et al. Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. Leukemia. 2016;30:2055–63. https://doi.org/10.1038/leu.2016.110

    Article  CAS  PubMed  Google Scholar 

  7. Han LJ, Wang Y, Fan ZP, Huang F, Zhou J, Fu YW, et al. Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission. Br J Haematol. 2017;179:120–30. https://doi.org/10.1111/bjh.14854

    Article  CAS  PubMed  Google Scholar 

  8. Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25 https://doi.org/10.1186/s13045-017-0398-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Atilla E, Atilla PA, Bozdag SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403–11. https://doi.org/10.1007/s15010-017-1016-1

    Article  CAS  PubMed  Google Scholar 

  10. Reisner Y, Aversa F, Martelli MF. Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transpl. 2015;50:S1–5. https://doi.org/10.1038/bmt.2015.86

    Article  Google Scholar 

  11. Sun Y, Beohou E, Labopin M, Volin L, Milpied N, Yakoub-Agha I, et al. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database. Haematological. 2016;101:e352–4. https://doi.org/10.3324/haematol.2015.140509

    Article  Google Scholar 

  12. Bashey A, Zhang X, Jackson K, Brown S, Ridgeway M, Solh M, et al. Comparison of outcomes of hematopoietic cell transplants from T-Replete haploidentical donors using post-transplantation cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 allele-matched unrelated donors and HLA-Identical sibling donors: a multivariable analysis including disease risk index. Biol Blood Marrow Transpl. 2016;22:125–33. https://doi.org/10.1016/j.bbmt.2015.09.002

    Article  CAS  Google Scholar 

  13. Pihusch R, Holler E, Muhlbayer D, Gohring P, Stotzer O, Pihusch M, et al. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transpl. 2002;30:347–54. https://doi.org/10.1038/sj.bmt.1703640

    Article  CAS  Google Scholar 

  14. Nevo S, Enger C, Swan V, Wojno KJ, Fuller AK, Altomonte V, et al. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival. Transplantation. 1999;67:681.

    Article  CAS  Google Scholar 

  15. Yeh S, Liao Y, Hsu C, Chen C, Shen Y, Hsueh C, et al. Gastric bleeding due to graft-versus-host disease: discrepancy between endoscopic and histologic assessment. Am J Clin Pathol. 2004;122:919–25. https://doi.org/10.1309/23DAL9F6P74XWJHL

    Article  PubMed  Google Scholar 

  16. Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037 https://doi.org/10.1038/nrdp.2016.37

    Article  PubMed  Google Scholar 

  17. Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematological. 2013;98:437–43. https://doi.org/10.3324/haematol.2012.069559

    Article  Google Scholar 

  18. Labrador J, Lopez-Corral L, Vazquez L, Sanchez-Guijo F, Guerrero C, Sanchez-Barba M, et al. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant. Br J Haematol. 2015;169:719–25. https://doi.org/10.1111/bjh.13344

    Article  PubMed  Google Scholar 

  19. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008;112:504–10. https://doi.org/10.1182/blood-2007-10-117051

    Article  CAS  PubMed  Google Scholar 

  20. Pihusch R, Salat C, Schmidt E, Gohring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002;74:1303–9. https://doi.org/10.1097/00007890-200211150-00018

    Article  PubMed  Google Scholar 

  21. Nevo S, Swan V, Enger C, Wojno KJ, Bitton R, Shabooti M, et al. Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood. 1998;91:1469–77.

    Article  CAS  Google Scholar 

  22. Kumar S, Dispenzieri A, Lacy MQ, Litzow MR, Gertz MA. High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transpl. 2001;28:381–5. https://doi.org/10.1038/sj.bmt.1703155

    Article  CAS  Google Scholar 

  23. Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F, et al. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987–1997: incidence, causes, and outcome. Am J Gastroenterol. 2001;96:385–93. https://doi.org/10.1016/S0002-9270(00)02342-X

    Article  CAS  PubMed  Google Scholar 

  24. Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol. 2004;41:93–100. https://doi.org/10.1053/j.seminhematol.2003.11.018

    Article  PubMed  Google Scholar 

  25. Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transpl. 2001;27:65–72. https://doi.org/10.1038/sj.bmt.1702717

    Article  CAS  Google Scholar 

  26. Yan CH, Xu LP, Wang FR, Chen H, Han W, Wang Y, et al. Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transpl. 2016;51:391–7. https://doi.org/10.1038/bmt.2015.306

    Article  CAS  Google Scholar 

  27. Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401–15. https://doi.org/10.1038/s41409-018-0204-7

    Article  Google Scholar 

  28. Zuckerman GR, Prakash C, Askin MP, Lewis BS. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology. 2000;118:201–21. https://doi.org/10.1016/S0016-5085(00)70430-6

    Article  CAS  PubMed  Google Scholar 

  29. Kaur S, Cooper G, Fakult S, Lazarus HM. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci. 1996;41:598–603. https://doi.org/10.1007/BF02282348

    Article  CAS  PubMed  Google Scholar 

  30. Ramos GP, Binder M, Hampel P, Braga NM, Sunjaya D, Al BB, et al. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia. Gastrointest Endosc. 2018;88:55–61. https://doi.org/10.1016/j.gie.2018.01.028

    Article  PubMed  Google Scholar 

  31. Nagata N, Sakurai T, Shimbo T, Moriyasu S, Okubo H, Watanabe K, et al. Acute severe gastrointestinal tract bleeding is associated with an increased risk of thromboembolism and death. Clin Gastroenterol H. 2017;15:1882–9. https://doi.org/10.1016/j.cgh.2017.06.028

    Article  Google Scholar 

  32. Kim K, Han BJ, Yang S, Na SY, Park S, Boo S, et al. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn’s disease. Digest Liver Dis. 2012;44:723–8. https://doi.org/10.1016/j.dld.2012.03.010

    Article  Google Scholar 

  33. Deutsch D, Romegoux P, Boustiere C, Sabate JM, Benamouzig R, Albaladejo P. Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study. Ther Adv Gastroenterol. 2019;12:321926755 https://doi.org/10.1177/1756284819851677

    Article  Google Scholar 

  34. Aoki T, Nagata N, Shimbo T, Niikura R, Sakurai T, Moriyasu S, et al. Development and validation of a risk scoring system for severe acute lower gastrointestinal bleeding. Clin Gastroenterol H. 2016;14:1562–70. https://doi.org/10.1016/j.cgh.2016.05.042

    Article  Google Scholar 

  35. Strate LL, Saltzman JR, Ookubo R, Mutinga ML, Syngal S. Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol. 2005;100:1821–7. https://doi.org/10.1111/j.1572-0241.2005.41755.x

    Article  PubMed  Google Scholar 

  36. Strate LL, Orav EJ, Syngal S. Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med. 2003;163:838 https://doi.org/10.1001/archinte.163.7.838

    Article  PubMed  Google Scholar 

  37. Xavier SA, Machado FJ, Magalhães JT, Cotter JB. Acute lower gastrointestinal bleeding: are STRATE andBLEED scores valid in clinical practice? Colorectal Dis. 2018. https://doi.org/10.1111/codi.14529.

  38. Aoki T, Yamada A, Nagata N, Niikura R, Hirata Y, Koike K. External validation of the NOBLADS score, a risk scoring system for severe acute lower gastrointestinal bleeding. Plos One. 2018;13:e196514 https://doi.org/10.1371/journal.pone.0196514

    Article  CAS  Google Scholar 

  39. Quach DT, Nguyen NT, Vo UP, Le LT, Vo CH, Ho PT, et al. Development and validation of a scoring system to predict severe acute lower gastrointestinal bleeding in vietnamese. Digest Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06253-y

    Article  PubMed  Google Scholar 

  40. Lee KK, Shah SM, Moser MA. Risk factors predictive of severe diverticular hemorrhage. Int J Surg. 2011;9:83–5. https://doi.org/10.1016/j.ijsu.2010.09.011

    Article  PubMed  Google Scholar 

  41. Wang X, Han W, Zhao P, Liu X, Wang J, Wang F, et al. Incidence, risk factors, outcomes, and risk score model of acute pancreatitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Tr. 2020;26:1171–8. https://doi.org/10.1016/j.bbmt.2019.12.721

    Article  Google Scholar 

  42. Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol. 2012;175:715–24. https://doi.org/10.1093/aje/kwr374

    Article  PubMed  PubMed Central  Google Scholar 

  43. Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631–60. https://doi.org/10.1002/sim.1742

    Article  PubMed  Google Scholar 

  44. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, et al. Novel model to predict gastrointestinal bleeding during left ventricular assist device support. Circ Heart Fail. 2018;11:e5267 https://doi.org/10.1161/CIRCHEARTFAILURE.118.005267

    Article  Google Scholar 

  45. Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303–14.

    CAS  PubMed  Google Scholar 

  46. Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood. 2012;120:2545–52. https://doi.org/10.1182/blood-2012-04-424135. 2774

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2014;49:966–71. https://doi.org/10.1038/bmt.2014.69

    Article  CAS  Google Scholar 

  48. Tuncer HH. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012;18:1851 https://doi.org/10.3748/wjg.v18.i16.1851

    Article  PubMed  PubMed Central  Google Scholar 

  49. Zhang X, Liu X, Wang Q, He Y, Zhu X, Zhang J, et al. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome. Eur J Haematol. 2018;100:171–81. https://doi.org/10.1111/ejh.12996

    Article  CAS  PubMed  Google Scholar 

  50. Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev. 2003;17:S6–10. https://doi.org/10.1016/s0268-960x(03)90001-4

    Article  PubMed  Google Scholar 

  51. Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191–204. https://doi.org/10.1016/j.blre.2014.11.001

    Article  PubMed  Google Scholar 

  52. El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation. Biol Blood Marrow Tr. 2015;21:1994–2001. https://doi.org/10.1016/j.bbmt.2015.06.016

    Article  Google Scholar 

  53. Ly KN, Xing J, Klevens RM, Jiles RB, Holmberg SD. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis. 2013;58:40–9. https://doi.org/10.1093/cid/cit642

    Article  PubMed  Google Scholar 

  54. Mikulska M, Nicolini L, Signori A, Rivoli G, Del BV, Raiola AM, et al. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2014;20:O694–701. https://doi.org/10.1111/1469-0691.12611

    Article  CAS  PubMed  Google Scholar 

  55. Mallet V, van Bommel F, Doerig C, Pischke S, Hermine O, Locasciulli A, et al. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis. 2016;16:606–17. https://doi.org/10.1016/S1473-3099(16)00118-3

    Article  PubMed  Google Scholar 

  56. Rencuzogullari A, Binboga S, Aytac E, Rabets J, Stocchi L, Ozuner G. Incidence, management, and risk factors for lower gastrointestinal bleeding in renal transplant recipients. Transpl P. 2017;49:501–4. https://doi.org/10.1016/j.transproceed.2017.02.001

    Article  CAS  Google Scholar 

  57. Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int. 2001;59:1510–9. https://doi.org/10.1046/j.1523-1755.2001.0590041510.x

    Article  CAS  PubMed  Google Scholar 

  58. Aggarwal A, Pant R, Kumar S, Sharma P, Gallagher C, Tatooles AJ, et al. Incidence and Management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg. 2012;93:1534–40. https://doi.org/10.1016/j.athoracsur.2012.02.035

    Article  PubMed  Google Scholar 

  59. Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y, et al. Risk score to predict gastrointestinal bleeding after acute ischemic stroke. BMC Gastroenterol. 2014;14:130 https://doi.org/10.1186/1471-230X-14-130

    Article  PubMed  PubMed Central  Google Scholar 

  60. Shalev A, Zahger D, Novack V, Etzion O, Shimony A, Gilutz H, et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol. 2012;157:386–90. https://doi.org/10.1016/j.ijcard.2010.12.081

    Article  PubMed  Google Scholar 

  61. Wang L, Pei D, Ouyang YQ, Nie X. Meta-analysis of risk and protective factors for gastrointestinal bleeding after percutaneous coronary intervention. Int J Nurs Pract. 2019;25:e12707 https://doi.org/10.1111/ijn.12707

    Article  PubMed  Google Scholar 

  62. Kelly JP, Kaufman DW, Koff RS, Laszlo A, Wiholm BE, Shapiro S. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol. 1995;90:1058–64.

    CAS  PubMed  Google Scholar 

  63. Kaufman DW, Kelly JP, Wiholm BE, Laszlo A, Sheehan JE, Koff RS, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94:3189–96. https://doi.org/10.1111/j.1572-0241.1999.01517.x

    Article  CAS  PubMed  Google Scholar 

  64. Lauffenburger JC, Rhoney DH, Farley JF, Gehi AK, Fang G. Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy. Pharmacotherapy. 2015;35:560–8. https://doi.org/10.1002/phar.1597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, et al. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur Heart J. 2009;30:2226–32. https://doi.org/10.1093/eurheartj/ehp256

    Article  PubMed  Google Scholar 

  66. Nelson AM, Juckett MB, Coe CL, Costanzo ES. Illness perceptions predict health practices and mental health following hematopoietic stem cell transplantation. Psychooncology. 2019;28:1252–60. https://doi.org/10.1002/pon.5075

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Key Research and Development Programme of China (No. 2017YFA0105503, No. 2017YFA0105500), Key Programme of National Natural Science Foundation of China (No. 81730004), National Natural Science Foundation of China (No. 81670116), Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), Beijing Natural Science Foundation (No. 7171013, H2018206423) and Beijing Municipal Science and Technology Commission (No. Z171100001017084).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaohui Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, X., Su, Y., Liu, X. et al. Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models. Bone Marrow Transplant 56, 1341–1351 (2021). https://doi.org/10.1038/s41409-020-01187-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-01187-5

This article is cited by

Search

Quick links